Amazon Prime Early Access sale, Consumer Price Index, bank earnings top week ahead
FOX Business takes a look at the upcoming events that are likely to move financial markets in the coming days.
Rivian announces major recall of vehicles
The electric vehicle manufacturer Rivian has announced a massive recall of 13,000 of its vehicles due to a safety problem.
CVS in exclusive talks to acquire Cano Health: report
Shares of Cano Health climbed on Friday following a report the value-based primary care provider is in exclusive talks to be bought by CVS Health. The Miami-based healthcare provider went public in June 2021.
Credit Suisse to buy back $3B in debt, sell Hotel Savoy
The Swiss bank's debt buyback plans come in an effort to calm market jitters related to its financial health. Credit Suisse shares jumped more than 10% on Friday.
DraftKings shares jump on ESPN brand partnership reports
DraftKings, which has a "great, long-standing relationship with ESPN", told FOX Business it speaks to a variety of companies on a regular basis and does not comment on those conversations.
Jobs data, AMD shares fall and more: Friday's 5 things to know
All eyes will be on the most anticipated economic report of the month as the September jobs report is released.
Samsung's earnings plunge on big drop-off in chip demand
Samsung's preliminary earnings report put up a red flag for the tech industry as a drop in demand cut into the bottomline.
Amazon puts brakes on live tests of home delivery robot
Amazon has decided to halt the live tests of its Scout delivery robot after the company said that it wasn't meeting the needs of customers.
How a social media frenzy around Credit Suisse rattled its stock
Online forums, including Twitter and Reddit, have been playing an outsized role in affecting the value of companies like GameStop, AMC and Credit Suisse.
Peloton cuts another 500 jobs, completing 'vast majority' of restructuring
Peloton CEO Barry McCarthy said in a memo to employees that the cuts mark the completion of the "vast majority" of its restructuring plan launched in February.
Job watch, oil rises and more: Thursday's 5 things to know
The markets focus for the rest of the week will be on jobs with unemployment benefits Thursday and the monthly jobs report on Friday.
Musk may need more financing firms for Twitter deal
Talks ended between Elon Musk and two major sources of financing for his takeover of Twitter.
Twitter, Elon Musk's Oct. 17 trial to proceed, judge says
Twitter and Elon Musk's trial over the Tesla CEO's attempt to walk away from his $44 billion acquisition of the social media giant will proceed as planned, according to a filing from Chancellor Kathaleen McCormick.
Hurricane Ian recovery efforts boost ProcureAM's FEMA ETF
The Procure Disaster Recovery Strategy ETF tracks a portfolio of about 60 companies engaged in recovering from natural disasters, such as hurricanes, wildfires, floods or earthquakes.
Twitter says it plans to close deal with Elon Musk
Twitter shares climbed on Tuesday after billionaire Tesla CEO Elon Musk offered to buy the social media giant at his original $54.20 per share offer.
91% of CEOs see tougher recession: KPMG
Recessionary fears are top of mind for the nation's CEOs, many of whom are positioning their businesses for a sharper downturn.
Viasat to sell military communications unit to L3Harris for nearly $2B
Viasat's Link 16 Tactical Data Links product line consists of 450 employees and generates approximately $400M in annual sales. The deal is expected to close in the first half of 2023.
Market strategist Brian Belski predicts 'massively bearish' investors can expect a market rebound in 2023
Market strategist Brian Belski shared his market predictions for the upcoming two years on 'Varney & Co.' Monday, saying the market will rebound in 2023.
Jobs data, Elon Musk's rescheduled Twitter deposition, Levi Strauss earnings top week ahead
FOX Business takes a look at the upcoming events likely to shake financial markets in the coming days, including earnings reports from Conagra and Levi's.
Moderna turns down China request for vaccine technology: report
Moderna has so far refused to make a deal for its COVID-19 vaccine with China, due to Beijing wanting the intellectual property behind it.


















